Novel quinolinone-phosphonic acid AMPA antagonists devoid of nephrotoxicity
Authors:
- 1 September 2002
- journal article
- Published by Elsevier in Il Farmaco
- Vol. 57 (10) , 787-802
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Competitive AMPA antagonism: A novel mechanism for antiepileptic drugs?Drugs of the Future, 2001
- AMPA receptor antagonistsExpert Opinion on Therapeutic Patents, 1999
- PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORSAnnual Review of Pharmacology and Toxicology, 1997
- Structure−Activity Relationships in a Series of 2(1H)-Quinolones Bearing Different Acidic Function in the 3-Position: 6,7-Dichloro-2(1H)-oxoquinoline-3-phosphonic Acid, a New Potent and Selective AMPA/Kainate Antagonist with Neuroprotective PropertiesJournal of Medicinal Chemistry, 1996
- 6-(1H-Imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione hydrochloride (YM90K) and related compounds: structure-activity relationships for the AMPA-type non-NMDA receptorJournal of Medicinal Chemistry, 1994
- AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 hEuropean Journal of Pharmacology, 1993
- Molecular cloning and characterization of the rat NMDA receptorNature, 1991
- 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a Neuroprotectant for Cerebral IschemiaScience, 1990
- Cloning by functional expression of a member of the glutamate receptor familyNature, 1989
- Anticonvulsant Action of Excitatory Amino Acid AntagonistsScience, 1982